Sentence examples for representation company from inspiring English sources

By league rule, no person affiliated with a player representation company can maintain any ownership share of a team.

Greg Schaefer was named to the vacant post of chief operating officer at National Cable Communications, New York, a cable advertising sales representation company.

Mrs. Ruffa, 41, is the president of Liz Dunn Production Management, a performing arts consulting and representation company in New York.

"We are here 360 days a year," said John Everett, director of special markets for Breakston-Stern associates, a sales representation company with showrooms displaying the products of multiple companies.

"They're designed to mimic something you would see in a wine cellar," said Daphne Poser, a project manager for Levien & Company, a real estate project management and owners representation company, which oversaw the project.

And Interep Interactive in Los Angeles, a division of Interep National Radio Sales, agreed to acquire Winstar Interactive Media in New York, an online ad representation company, from Winstar Communications in New York.

There had been speculation in the music industry that IAC/InterActiveCorp, which is controlled by Barry Diller, would force Live Nation to extend its contract as a result of its acquisition in May of an interest in Front Line Management, one of the biggest talent representation companies, with a roster of live performers that includes the Eagles and Jimmy Buffett.

In the space of a year, SFX bought 14 private sports representation companies for a combined $1.5 billion and consolidated them into SFX Sports Group in 1999, naming Falk as Chairman.

Miller; a player-representation company set up by him called A.S.M.; and Creation Management, an entertainment agency that owns 50percentt of Wilhelmina Models, were found liable in New York Supreme Court in Manhattan for compensatory damages for the loss of Fleisher's clientele.

These small companies were a diverse representation of companies, including generic companies (20%), innovative pharmaceutical or biotech companies (40%), and other companies mainly consisting of medical technology companies, those working on new applications of drugs, and consultants.

The wide-ranging investigation will also consider the possibility of worker representation on company boards and remuneration committees, as well as the barriers to women rising to the top levels of management.